Asarina Pharma AB Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest, by Sven Göthe, was filed 28 May 2021.
Asarina Pharma AB: what insiders have been doing
Asarina Pharma AB is a listed company. Its directors and officers file their transactions with Finansinspektionen. Nothing new has been filed by managers of Asarina Pharma AB in twelve months, the latest record being from 3 September 2021.
The full history, which starts in 2018, counts 33 purchases against 5 sales.
For comparison within the same market, see the insider buying recorded at Dynavox Group AB and Rusta AB (publ). This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Financial data
· cache
- 4,250 shares@ SEK 2.73761.2% of flowAktieISIN SE0011641794FI:csv-f0af16297a475faa3225
- 18,832 shares@ SEK 2.73755.2% of flowAktieISIN SE0011641794FI:csv-cd9db2560785a08851ba
- 94,000 shares@ SEK 0.5311.2% of flowWarrantISIN SE0011641794FI:csv-76e16e83d94d7c0f6807Canonical exit: 26 Aug 2021 (T+90)
- 94,000 shares@ SEK 0.53100.0% of flowWarrantFI:csv-6e3e9cd4df08c0db6eaeCanonical exit: 26 Aug 2021 (T+90)
- 301,724 shares@ SEK 27.8028.0% of flowAktieISIN SE0011641794FI:csv-eb0580b73c6362da824c
- 18,832 shares@ SEK 21.7029.3% of flowAktieISIN SE0011641794FI:csv-cc59bf7e49dec684f2efCanonical exit: 16 Jun 2020 (T+90)
- 2,005 shares@ SEK 35.0058.1% of flowAktieISIN SE0011641794FI:csv-e96969d1fb8a4da4155cCanonical exit: 21 May 2020 (T+90)
- 5,000 shares@ SEK 30.3016.0% of flowAktieISIN SE0011641794FI:csv-d35daa521d7aac641055Canonical exit: 18 May 2020 (T+90)
- 61,000 shares@ SEK 5.0074.0% of flowWarrantFI:csv-2d70a003f19186f2a036Canonical exit: 28 Apr 2020 (T+90)
- 15,000 shares@ SEK 5.00100.0% of flowWarrantISIN SE0011641794FI:csv-8b79672b57ef7564f71cCanonical exit: 26 Apr 2020 (T+90)
- 41,000 shares@ SEK 5.00100.0% of flowWarrantFI:csv-e4cb11538c7655c81d08Canonical exit: 26 Apr 2020 (T+90)
- 500 shares@ SEK 22.801.2% of flowAktieISIN SE0011641794FI:csv-81e00e3942f303c0ad22Canonical exit: 10 Feb 2020 (T+90)
- 1,000 shares@ SEK 23.002.4% of flowAktieISIN SE0011641794FI:csv-d579607a5114119dbcf2Canonical exit: 9 Feb 2020 (T+90)
- 800 shares@ SEK 23.501.9% of flowAktieISIN SE0011641794FI:csv-620a0b27b9a09e4ad7a2Canonical exit: 9 Feb 2020 (T+90)
- 500 shares@ SEK 22.801.2% of flowAktieISIN SE0011641794FI:csv-6de16275b252b62f414dCanonical exit: 6 Feb 2020 (T+90)
- 500 shares@ SEK 21.801.1% of flowAktieISIN SE0011641794FI:csv-ace0eb0d43ca231b9cb8Canonical exit: 4 Feb 2020 (T+90)
- 450 shares@ SEK 22.401.0% of flowAktieISIN SE0011641794FI:csv-8d304a8c87be26769b2cCanonical exit: 2 Feb 2020 (T+90)
- 500 shares@ SEK 21.501.1% of flowAktieISIN SE0011641794FI:csv-486f50818202c86791edCanonical exit: 29 Jan 2020 (T+90)
- 574,284 shares@ SEK 22.0042.9% of flowAktieISIN SE0011641794FI:csv-7bd8a8ba6bfbc7d39445
- 300 shares@ SEK 25.000.8% of flowAktieISIN SE0011641794FI:csv-975d8b4a377671cb5077Canonical exit: 31 Dec 2019 (T+90)
- 2,000 shares@ SEK 25.5041.9% of flowAktieISIN SE0011641794FI:csv-0f9a33977156a67c72f3Canonical exit: 23 Dec 2019 (T+90)
- 5,114 shares@ SEK 25.900.5% of flowAktieISIN SE0011641794FI:csv-e6cf38192528c3edafa9
- 58,934 shares@ SEK 25.93675.2% of flowAktieISIN SE0011641794FI:csv-47dbbcb88353a503be50
- 400 shares@ SEK 25.501.1% of flowAktieISIN SE0011641794FI:csv-b41e8ee959d7cd1bbcebCanonical exit: 9 Dec 2019 (T+90)
- 1,022 shares@ SEK 25.8752.7% of flowAktieISIN SE0011641794FI:csv-814bb56138ba59b1f203Canonical exit: 28 Nov 2019 (T+90)
25 of 41 declarations
About Asarina Pharma AB
Asarina Pharma AB is a Swedish biopharmaceutical company focused on developing treatments for neurological diseases. It is listed on the Stockholm Stock Exchange (XSTO).
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations